Rutger-Jan Swijnenburg (@rj_swijnenburg) 's Twitter Profile
Rutger-Jan Swijnenburg

@rj_swijnenburg

ID: 1667519830470144001

calendar_today10-06-2023 13:11:58

4 Tweet

28 Followers

9 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
Jean-Nicolas Vauthey MD (@vautheymd) 's Twitter Profile Photo
Jean-Nicolas Vauthey MD
@vautheymd

2 years ago

Congratulations Dr. Swijnenburg for CAIRO-5 🇳🇱 presentation E-AHPBA in Lyon 👏 In unresectable #colorectalcancer #metastasis triplet FOLFOXIRI with bevacizumab or panitumumab better response, resectability and PFS than doublet #oncsurgery SSAT Society of Surgical Oncology IHPBA AHPBA

Congratulations Dr. Swijnenburg for CAIRO-5 🇳🇱 presentation <a href="/EAHPBA/">E-AHPBA</a> in Lyon 👏 In unresectable #colorectalcancer #metastasis triplet FOLFOXIRI with bevacizumab or panitumumab better response, resectability and PFS than doublet #oncsurgery <a href="/SSATNews/">SSAT</a> <a href="/SocSurgOnc/">Society of Surgical Oncology</a> <a href="/IHPBA/">IHPBA</a> <a href="/AHPBA/">AHPBA</a>
Andreas Schnitzbauer (@aschnitzb) 's Twitter Profile Photo
Andreas Schnitzbauer
@aschnitzb

2 years ago

Rutger-Jan Swijnenburg

Marc Besselink (@marcbesselink) 's Twitter Profile Photo
Marc Besselink
@marcbesselink

a year ago

Is ICG-fluorescence 🟢 useful during #robot 🤖 and laparoscopic #liver #surgery for #CRLM? Today #MIMIC trial in JAMA Network Open Rutger-Jan Swijnenburg 🔑 Prosp study 225 pts, ICG-fluorescence imaging ⬆️ R0 resection and changed surgical management in 28% of pts. 🔑 The absence of

Is ICG-fluorescence 🟢 useful during #robot 🤖 and laparoscopic #liver #surgery for #CRLM? Today #MIMIC trial in <a href="/JAMANetworkOpen/">JAMA Network Open</a> <a href="/rj_swijnenburg/">Rutger-Jan Swijnenburg</a> 🔑 Prosp study 225 pts, ICG-fluorescence imaging ⬆️ R0 resection and changed surgical management in 28% of pts. 🔑 The absence of
JAMA Oncology (@jamaonc) 's Twitter Profile Photo
JAMA Oncology
@jamaonc

8 months ago

CAIRO5 RCT: No overall survival benefit was found for different induction regimens in patients with initially unresectable colorectal cancer liver metastases; FOLFOX/FOLFIRI plus bevacizumab is recommended. ja.ma/3Zfx1gz

CAIRO5 RCT: No overall survival benefit was found for different induction regimens in patients with initially unresectable colorectal cancer liver metastases; FOLFOX/FOLFIRI plus bevacizumab is recommended. ja.ma/3Zfx1gz